aim:We aimed to compare the performance of nine adrenal steroids in confirming the correct catheter position during adrenal venous sampling (AVS) without cosyntropin in patients with primary hyperaldosteronism. materials & methods: A successful adrenal vein catheterization without cosyntropin was defined as the ratio of steroids from adrenal to peripheral veins being >3:1. AVS samples from four patients with primary hyperaldosteronism were analyzed. results: Compared with the mean ratio of cortisol without cosyntropin, the ratios of 11-deoxycortisol (p = 0.008), dehydroepiandrosterone (p = 0.01) and androstenedione (p = 0.008) were significantly higher. None of the ratios (n = 8) of cortisol from adrenal to peripheral veins exceeded 3:1, while all ratios of 11-deoxycortisol (p < 0.001) were >3. Conclusion: Cosyntropin infusion during AVS may not be necessary if 11-deoxycortisol is used to confirm catheter position. • Because imaging alone cannot reliably distinguish aldosterone-producing adenoma from commonly detected nonfunctioning adrenal nodules. Adrenal venous sampling is considered the gold standard for selecting patients who would benefit from an adrenalectomy.• There are two areas that need to be assessed from adrenal venous sampling: the position of the catheter when the samples are collected and a comparison of normalized aldosterone production from each adrenal gland.• To confirm a successful adrenal vein catheterization, a commonly used criterion is the ratio of cortisol from the adrenal vein to the peripheral vein greater than 3:1 without cosyntropin infusion.• Compared with the cosyntropin-stimulated cortisol ratio of adrenal to peripheral veins, the nonstimulated ratio can be falsely low, suggesting incorrect catheter placement occurred in approximately 50% of the samples.• Our pilot study suggests that 11-deoxycortisol is more accurate in identifying correct position of the catheter than cortisol without cosyntropin infusion. Thus, it can simplify the procedure and reduce false-negative results associated with cosyntropin infusion.For reprint orders, please contact: reprints@futuremedicine.com